Senior Research Associate in Evidence Synthesis

This is an exciting opportunity for a highly motivated and experienced researcher with an enthusiasm for quantitative evidence synthesis. You will join the Bristol NIHR Evidence Synthesis Group, one of nine groups contracted by the NIHR to conduct evidence syntheses within the NIHR remit.
You will work as part of a multi-disciplinary team benefiting from working alongside international leaders in the field of evidence synthesis. You will also work closely with other team members including other reviewers, statisticians, information specialists, qualitative researchers and health economists.

As a lead reviewer, you will manage the day-to-day review processes and project-related administration. You will also make contributions to other ESG reviews, across all aspects of the process, including screening to identify studies eligible for inclusion in the review; extraction of information about included studies; evaluation of the quality or risk of bias of the included studies; and synthesis of the results of these studies using an appropriate approach (e.g., using meta-analysis or descriptive syntheses). There will be opportunities to develop methodological research projects related to the applied reviews commissioned by NIHR. You will contribute to the preparation of reports and papers for publication and participate effectively in activities to maximise engagement with research and/or impact beyond academia.

You have:
•    A PhD in epidemiology, public health, medical statistics or other relevant quantitative discipline
•    Significant experience of research in an academic setting
•    Experience of conducting systematic reviews, scoping reviews, rapid reviews or overviews of various types of evidence
•    Experience of preparing reports and papers for publication
•    A systematic and thorough approach to work with a high level of attention to detail
•    Excellent organisational and time management skills
•    Excellent written and oral communication skills
A commitment to team working, professionalism and respect for others

Contract type: Open ended with funding until 31/03/2028

Work pattern: Full Time (Part Time considered)

Grade: J Pathway 2

Salary: £41,732 - £44,263 per annum (pro-rata)

School/Unit: 

Shift pattern: Bristol Medical School

Interview potential date: Week beginning 13th May 2024

For informal queries, please contact:

Professor Julian Higgins ([email protected])

Professor Deborah Caldwell ([email protected])

This advert will close at23:59 GMTon 29/04/2024

We recently launched our strategy  to 2030 tying together our mission, vision and values.

The University of Bristol aims to be a place where everyone feels able to be themselves and do their best in an inclusive working environment where all colleagues can thrive and reach their full potential. We want to attract, develop, and retain individuals with different experiences, backgrounds and perspectives – particularly people of colour, LGBT+ and disabled people - because diversity of people and ideas remains integral to our excellence as a global civic institution.

This is an exciting opportunity for a highly motivated and experienced researcher with an enthusiasm for quantitative evidence synthesis. You will join the Bristol NIHR Evidence Synthesis Group, one of nine groups contracted by the NIHR to conduct evidence syntheses within the NIHR remit.
You will work as part of a multi-disciplinary team benefiting from working alongside international leaders in the field of evidence synthesis. You will also work closely with other team members including other reviewers, statisticians, information specialists, qualitative researchers and health economists.

As a lead reviewer, you will manage the day-to-day review processes and project-related administration. You will also make contributions to other ESG reviews, across all aspects of the process, including screening to identify studies eligible for inclusion in the review; extraction of information about included studies; evaluation of the quality or risk of bias of the included studies; and synthesis of the results of these studies using an appropriate approach (e.g., using meta-analysis or descriptive syntheses). There will be opportunities to develop methodological research projects related to the applied reviews commissioned by NIHR. You will contribute to the preparation of reports and papers for publication and participate effectively in activities to maximise engagement with research and/or impact beyond academia.

You have:
•    A PhD in epidemiology, public health, medical statistics or other relevant quantitative discipline
•    Significant experience of research in an academic setting
•    Experience of conducting systematic reviews, scoping reviews, rapid reviews or overviews of various types of evidence
•    Experience of preparing reports and papers for publication
•    A systematic and thorough approach to work with a high level of attention to detail
•    Excellent organisational and time management skills
•    Excellent written and oral communication skills
A commitment to team working, professionalism and respect for others

Contract type: Open ended with funding until 31/03/2028

Work pattern: Full Time (Part Time considered)

Grade: J Pathway 2

Salary: £41,732 - £44,263 per annum (pro-rata)

School/Unit: 

Shift pattern: Bristol Medical School

Interview potential date: Week beginning 13th May 2024

For informal queries, please contact:

Professor Julian Higgins ([email protected])

Professor Deborah Caldwell ([email protected])

This advert will close at23:59 GMTon 29/04/2024

We recently launched our strategy  to 2030 tying together our mission, vision and values.

The University of Bristol aims to be a place where everyone feels able to be themselves and do their best in an inclusive working environment where all colleagues can thrive and reach their full potential. We want to attract, develop, and retain individuals with different experiences, backgrounds and perspectives – particularly people of colour, LGBT+ and disabled people - because diversity of people and ideas remains integral to our excellence as a global civic institution.